Predictive Models Utilizing Machine Learning for Visual Impairment in Chinese Adults Aged 45 and Older with Cardiovascular Metabolic Conditions: Insights from a Population-Based Analysis Using CHARLS - Scorecard - MDSpire

Predictive Models Utilizing Machine Learning for Visual Impairment in Chinese Adults Aged 45 and Older with Cardiovascular Metabolic Conditions: Insights from a Population-Based Analysis Using CHARLS

  • By

  • Yuhao Liu

  • Riyan Zhang

  • Duoduo Xie

  • Min Liu

  • Guanshun Yu

  • Zhong Lin

  • Jia Qu

  • Ronghan Wu

  • December 30, 2025

  • 0 min

Share

Clinical Scorecard: Predictive Models Utilizing Machine Learning for Visual Impairment in Chinese Adults Aged 45 and Older with Cardiovascular Metabolic Conditions: Insights from a Population-Based Analysis Using CHARLS

At a Glance

CategoryDetail
ConditionVisual Impairment (VI)
Key MechanismsHyperglycemia, hypertension, and lipid abnormalities damaging the retina and optic nerve; systemic vascular events impairing circulation.
Target PopulationChinese adults aged 45 and older with Cardiometabolic Diseases (CMD)
Care SettingPrimary care settings

Key Highlights

  • VI affects over 2.2 billion individuals globally, impacting quality of life.
  • CMD patients are at elevated risk for VI due to systemic health issues.
  • Machine learning models can predict VI risk in CMD populations.
  • CHARLS data utilized for model development and validation.
  • Timely assessment of VI in CMD patients is often challenging.

Guideline-Based Recommendations

Diagnosis

  • Utilize self-reported vision assessments to classify VI.

Management

  • Implement early screening for VI in CMD patients.

Monitoring & Follow-up

  • Regular follow-up assessments for vision-related functional limitations.

Risks

  • Increased risk of psychological distress and caregiver burden associated with VI.

Patient & Prescribing Data

Adults aged ≥ 45 years with diagnosed CMD.

Focus on timely clinical interventions to prevent vision loss.

Clinical Best Practices

  • Incorporate machine learning tools for risk prediction in clinical settings.
  • Ensure CMD patients receive comprehensive vision assessments.

References

Original Source(s)

Related Content